Weight Loss Injections Scotland | Cured Pharmacy UK
UK Registered Pharmacy - Weight Loss Injections Scotland
Takes less than 2 minutes to complete 100% online
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen
Wegovy (Semaglutide) Weight Loss Injection
Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER
Weight Loss Injections Scotland: Your Complete Guide
Published on: June 03, 2026
Accessing weight loss injections Scotland UK pharmacy services has never been more straightforward. Cured Pharmacy offers Scottish patients genuine UK-licensed weight loss treatments including Mounjaro, Wegovy, and Saxenda, with free online consultations from UK prescribers and discreet delivery to every postcode across Scotland.
Weight Loss Injections Available in Scotland
Scottish patients now have access to three MHRA-licensed injectable weight loss treatments through our UK-registered pharmacy. Mounjaro (tirzepatide) represents the latest advancement as the first dual GIP/GLP-1 receptor agonist, demonstrating average weight reductions of up to 22.5% over 72 weeks in clinical trials [1]. Wegovy (semaglutide) offers once-weekly injections with proven efficacy, whilst Saxenda (liraglutide) provides a daily injection option for those preferring more frequent dosing.
Each treatment works by mimicking natural gut hormones that regulate appetite and blood sugar levels. Clinical trials have consistently shown these medications produce significantly greater weight loss than diet and exercise alone when used as part of a comprehensive weight management programme [1][2]. All three are prescription-only medicines requiring assessment by a UK prescriber before dispensing.
How Weight Loss Injections Work
GLP-1 receptor agonists work by activating receptors in the brain that control appetite and food intake. These medications slow gastric emptying, helping you feel fuller for longer after meals, whilst also reducing cravings between eating occasions [2]. Mounjaro's dual-action mechanism additionally targets GIP receptors, which may explain its superior weight loss outcomes compared to single-pathway treatments in head-to-head trials.
The injectable format ensures consistent medication levels in your bloodstream, bypassing digestive breakdown that can reduce oral medication effectiveness. Most patients begin noticing appetite reduction within the first week of treatment, though optimal weight loss typically occurs gradually over several months as your body adjusts to the medication [3].
Expected Timeline and Results
Clinical trial data shows most significant weight loss occurs between weeks 12 and 52 of treatment, with many patients continuing to lose weight beyond one year when combined with lifestyle modifications [1][3]. Your UK prescriber will monitor your progress and adjust dosing as needed to optimise results whilst minimising side effects.
Online Consultation Process for Scottish Patients
Our streamlined online consultation takes under three minutes to complete from any location in Scotland. You'll answer medical history questions covering your weight loss goals, current medications, and relevant health conditions. A UK-registered prescriber reviews every assessment individually, ensuring the treatment is clinically appropriate and safe for your circumstances.
If approved, your prescription is sent electronically to our GPhC-registered pharmacy where our team dispenses genuine UK-licensed medication. We offer discreet packaging and next-day delivery options to addresses throughout Scotland, from Edinburgh and Glasgow to the Highlands and Islands. Prescription medications cannot be supplied without prescriber approval, ensuring patient safety remains our priority.
What Happens If Treatment Isn't Suitable
If our prescriber determines injectable weight loss treatment isn't appropriate for your current circumstances, they may suggest alternative options such as Orlistat tablets or recommend consulting your GP for additional support. We never charge consultation fees, so you're not financially penalised if treatment cannot be approved.
| Treatment | Active Ingredient | Injection Frequency | Starting Price |
|---|---|---|---|
| Mounjaro | Tirzepatide | Once weekly | From £124.99 |
| Wegovy | Semaglutide | Once weekly | From £69.00 |
| Saxenda | Liraglutide | Once daily | From £68.00 |
| Orlistat | Orlistat | Three times daily (oral) | From £32.00 |
Comparing Mounjaro, Wegovy, and Saxenda
Whilst all three medications belong to the GLP-1 class, important differences exist in their mechanisms, dosing schedules, and clinical outcomes. Mounjaro's dual GIP/GLP-1 action has demonstrated superior weight loss in clinical trials, with participants achieving greater percentage body weight reductions compared to semaglutide-based treatments [1][4]. However, individual response varies, and some patients may tolerate or respond better to one medication over another.
Wegovy offers a well-established safety profile with extensive real-world use data, making it a popular choice for patients preferring tried-and-tested options. Saxenda's daily injection schedule provides more frequent dosing, which some patients prefer for maintaining routine, though others find weekly injections more convenient. Your prescriber will discuss which option best aligns with your medical history, lifestyle preferences, and weight loss goals.
Side Effects and Safety Considerations
The most common side effects across all GLP-1 treatments include nausea, diarrhoea, constipation, and stomach discomfort, particularly during initial weeks or dose increases [2][3]. These gastrointestinal symptoms typically diminish as your body adjusts to the medication. Starting at lower doses and gradually titrating upward, as recommended in prescribing guidelines, significantly reduces side effect severity.
More serious but rare risks include pancreatitis, gallbladder problems, and thyroid concerns. Clinical trials have established comprehensive safety profiles for these medications, and your prescriber will screen for contraindications during assessment [4]. Scottish patients should report any persistent or severe side effects to their prescriber immediately and can contact our pharmacy team for advice during treatment.
Who Should Not Use Weight Loss Injections
These medications are not suitable for pregnant or breastfeeding women, individuals with personal or family history of medullary thyroid carcinoma, or those with multiple endocrine neoplasia syndrome type 2. Your prescriber will assess your complete medical history to ensure treatment safety before prescribing.
Pricing and Delivery Across Scotland
Cured Pharmacy offers transparent upfront pricing with no hidden consultation fees. You'll see exact costs before completing your medical assessment, allowing informed decision-making about your treatment investment. We guarantee competitive UK pricing on all weight loss medications, with Mounjaro available from £135.00, ensuring Scottish patients access the same affordable rates as customers throughout the UK.
We provide reliable delivery services to every Scottish postcode, including remote and island communities. Standard delivery typically arrives within 2-3 working days, whilst next-day options are available for urgent orders placed before our cut-off time. All medications are packaged discreetly with no external markings indicating contents, protecting your privacy throughout the delivery process. Our pharmacy team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensures every order meets rigorous quality and safety standards before dispatch.
Scientific References
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment alongside appropriate diet and exercise modifications.
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.